Related Experiment Video
Updated: Jan 15, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Influenza vaccine hesitancy in the elderly: Where do we stand?
1CBIOS - Research Center for Biosciences and Health Technologies, University Lusófona, Lisbon, Portugal; Campo Grande 376, 1749-024 Lisboa, Portugal.
Understanding influenza vaccine hesitancy in the elderly is crucial for public health. Sociodemographic factors and the 5C Model elements significantly influence older adults
Area of Science:
- Public Health
- Epidemiology
- Gerontology
Background:
- Seasonal influenza poses significant health risks, particularly for elderly populations.
- Vaccine hesitancy among older adults remains a critical public health concern.
- Effective influenza vaccination strategies require understanding hesitancy factors.
Purpose of the Study:
- To systematically review and analyze existing literature on influenza vaccine hesitancy in the elderly.
- To identify and categorize the primary factors contributing to vaccine hesitancy in older adults.
- To provide evidence-based recommendations for improving influenza vaccination uptake in this demographic.
Main Methods:
- A narrative review methodology was employed.
- Literature searches were conducted across PubMed, SciELO, and DOAJ databases.
- Studies published within the last ten years focusing on influenza vaccine hesitancy in older adults were included.
Main Results:
- Forty-three relevant papers were selected for analysis.
- Sociodemographic variables and components of the 5C Model (confidence, complacency, constraints, risk calculation, collective responsibility) were identified as key factors.
- These factors collectively explain a significant portion of influenza vaccine hesitancy in the elderly.
Conclusions:
- The study contributes valuable insights into influenza vaccine hesitancy among older adults.
- Identified factors can inform the development of targeted interventions and practical recommendations.
- The narrative approach and single-author design present limitations in analysis depth and generalizability.
Related Concept Videos
Vaccinations
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

